beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology
about
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomersAmyloid-beta neurotoxicity is mediated by FISH adapter protein and ADAM12 metalloprotease activityThe toxicity of amyloid β oligomersMammalian nicotinic acetylcholine receptors: from structure to functionFurin at the cutting edge: from protein traffic to embryogenesis and diseaseSynapses and Alzheimer's diseaseCalcium-Sensing Receptors of Human Neural Cells Play Crucial Roles in Alzheimer's DiseaseThe human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function"Is dopamine involved in Alzheimer's disease?"α7 nicotinic ACh receptors as a ligand-gated source of Ca(2+) ions: the search for a Ca(2+) optimumAlzheimer's disease, amyloid peptide and synaptic dysfunctionStructural evolution and membrane interactions of Alzheimer's amyloid-beta peptide oligomers: new knowledge from single-molecule fluorescence studiesAmyloid β precursor protein as a molecular target for amyloid β--induced neuronal degeneration in Alzheimer's diseaseThe dendritic hypothesis for Alzheimer's disease pathophysiology.Synaptopathies: synaptic dysfunction in neurological disorders - A review from students to studentsAβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic lossNMR structure of the water soluble Aβ17-34 peptideDirect observation of single amyloid-β(1-40) oligomers on live cells: binding and growth at physiological concentrationsRegulation of NMDA receptor trafficking by amyloid-betaNanoscale Synaptic Membrane Mimetic Allows Unbiased High Throughput Screen That Targets Binding Sites for Alzheimer's-Associated Aβ Oligomers.Uncovering the Molecular Mechanism of Actions between Pharmaceuticals and Proteins on the AD NetworkNa, K-ATPase α3 is a death target of Alzheimer patient amyloid-β assembly.The catalytic domain of insulin-degrading enzyme forms a denaturant-resistant complex with amyloid beta peptide: implications for Alzheimer disease pathogenesisMossy fiber long-term potentiation deficits in BACE1 knock-outs can be rescued by activation of alpha7 nicotinic acetylcholine receptorsPicomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus.Dendritic spine alterations in the hippocampus and parietal cortex of alpha7 nicotinic acetylcholine receptor knockout miceDeletion of the alpha 7 nicotinic acetylcholine receptor gene improves cognitive deficits and synaptic pathology in a mouse model of Alzheimer's diseaseThe functional therapeutic chemical classification systemMicroglia demonstrate age-dependent interaction with amyloid-β fibrilsCortical alpha7 nicotinic acetylcholine receptor and beta-amyloid levels in early Alzheimer disease.Amyloid-beta protofibril levels correlate with spatial learning in Arctic Alzheimer's disease transgenic mice.The multi-functional drug tropisetron binds APP and normalizes cognition in a murine Alzheimer's model.Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease.High throughput electrophysiology with Xenopus oocytesComputational identification of potential multitarget treatments for ameliorating the adverse effects of amyloid-β on synaptic plasticityNicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection.Alzheimer precursor protein interaction with the Nogo-66 receptor reduces amyloid-beta plaque depositionCellular prion protein mediates the toxicity of beta-amyloid oligomers: implications for Alzheimer disease.Calcium signaling and amyloid toxicity in Alzheimer disease.A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides
P2860
Q22251089-A241C7D6-8298-4F85-B15E-3828F4B0A550Q24556621-2BD29DD4-E47D-4A92-8985-6948FCA19BFCQ24631757-E3C9D8FD-598C-4B31-99BD-20CA3B7CF76CQ24647069-0754FAC2-75B0-46D1-B6D3-45FFA4157103Q24670432-91F7FC59-4DAA-4C5C-A33D-F341933E2E14Q26269868-84D5286A-E6BF-4195-8105-9DC823AB90B8Q26747527-5ABD1D9A-4A02-401D-8FD5-4A603DECC650Q26821785-B6055679-C41F-448D-BCD2-A3B5E6497619Q26851680-CD080692-AAB5-4E74-BBE5-FB2861255FEFQ26852967-3EF8DAD6-075B-4B16-8D01-5C98B5EF30B8Q27005935-09FDE674-2ED0-45A1-984B-EC985361DCA9Q27010584-B4B08F4B-7E02-41B0-AC63-249E3F562C07Q27012950-E403B9F9-17AB-4097-AF6F-425D9489258CQ27687404-A0297174-8661-4FCA-8BF0-85FD5C7D4EC3Q28077671-CFE8069E-22AC-457A-8D06-76FF92DD6D18Q28293023-25512564-BD85-4530-91A7-51E50D452704Q28382930-3DB8E301-6A82-43E0-9302-1A1DA553F875Q28476715-A8E31E5B-432B-4B14-9D74-84907282ACBAQ28506085-0A5E8CAA-860E-4370-9AB2-1DD0152B2475Q28546877-8C499349-D8F2-4755-B999-48F0362C3282Q28551442-A82BF59D-337E-4207-846B-AFA3857BDE3EQ28572007-E8E30BAF-DFB6-4B93-A54E-F09A55EA1CA1Q28574836-65C58D7F-E366-404D-942C-0464D431D3A7Q28590874-4BB39966-94CB-4A48-BA4A-0BCB7B4BB381Q28592777-7BAB408B-3355-4D62-AC19-C5BE4F356EC4Q28594309-55A73967-A48D-4D91-863F-0F9DD9FBF922Q28595059-511ABC0B-1C9F-4F52-A28B-262ACE00E976Q28657672-E22BD16A-FB09-464A-B9F7-9DC12C42B71EQ30427927-75A6C041-54FB-4DEF-9185-DA96E54CE959Q30436728-AB004F4F-1E77-4365-92D4-24CB3E963C4CQ30490529-B80FCEA3-1DF3-4219-9B36-6ACF5F7642F0Q30577199-2249E43A-415B-4302-AFB2-A71371BB4073Q32028060-9194C042-478E-4B38-B105-68E9822AF923Q33400496-EF3A3EB7-D46B-461A-B4ED-F500DF7EF961Q33611723-C3B96602-3BEE-4E68-AF1F-A6AA8B3DCAADQ33694502-95750A7D-EA40-478B-A3C3-2C1621B3C60FQ33756388-AD54B847-4094-438A-AD05-8D619E8134DFQ33768032-E5090007-8CD6-4831-987B-CE0E1B8B2E2EQ33799937-CF8B3D24-DFB9-4F51-A91E-DEEF54525CC5Q33801299-CA6D9D34-4B43-4675-B8F0-DC46C65FCCFD
P2860
beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
beta-Amyloid(1-42) binds to al ...... Alzheimer's disease pathology
@ast
beta-Amyloid(1-42) binds to al ...... Alzheimer's disease pathology
@en
beta-Amyloid(1-42) binds to al ...... Alzheimer's disease pathology
@en-gb
beta-Amyloid(1-42) binds to al ...... Alzheimer's disease pathology
@nl
type
label
beta-Amyloid(1-42) binds to al ...... Alzheimer's disease pathology
@ast
beta-Amyloid(1-42) binds to al ...... Alzheimer's disease pathology
@en
beta-Amyloid(1-42) binds to al ...... Alzheimer's disease pathology
@en-gb
beta-Amyloid(1-42) binds to al ...... Alzheimer's disease pathology
@nl
prefLabel
beta-Amyloid(1-42) binds to al ...... Alzheimer's disease pathology
@ast
beta-Amyloid(1-42) binds to al ...... Alzheimer's disease pathology
@en
beta-Amyloid(1-42) binds to al ...... Alzheimer's disease pathology
@en-gb
beta-Amyloid(1-42) binds to al ...... Alzheimer's disease pathology
@nl
P2093
P921
P3181
P356
P1476
beta-Amyloid(1-42) binds to al ...... Alzheimer's disease pathology
@en
P2093
P304
P3181
P356
10.1074/JBC.275.8.5626
P407
P577
2000-02-25T00:00:00Z